SPOTLIGHT -
EP. 1: Historical Management of Gastrointestinal Stromal Tumors
EP. 2: The INVICTUS Trial in GIST: Study Design and Results
EP. 3: The INVICTUS Trial in GIST: A New Class of TKI
EP. 4: The Intrigue Study in GIST: Study Design and Goals
EP. 5: Looking Toward the Future of Advanced GIST Management
EP. 6: Other Noteworthy Data From the 2019 ESMO Meeting
Dr Berkenstock on ADC-Related Ocular Toxicities in Cervical and Ovarian Cancers
Dr Matalonis on the Management of Mirvetuximab Soravtansine-Related Toxicities in FRα+ Ovarian Cancer
Updated EMPOWER-Lung 3 Data Support Frontline Cemiplimab Plus Chemo in Advanced NSCLC
Neoadjuvant Nivolumab Plus Chemotherapy Retains EFS Advantage in Resectable NSCLC
